Intravenous Infusions is trading 7.1% down at GHS 0.78 following several days of sharp gains and pullbacks, suggesting potential profit-taking or low-liquidity volatility rather than a news-driven move.
- There have been no fresh company-specific announcements, earnings reports, or regulatory headlines to account for the price action.
- Broader Ghana Stock Exchange indices are trading modestly higher, indicating that the decline is idiosyncratic and not part of a wider market selloff.